US OptionsDetailed Quotes

CLRB240816C5000

Watchlist

0.05
-0.05-50.00%

15min DelayClose Jul 23 15:58 ET

0.05High0.01Low

Cellectar BioSciences Stock Discussion

Trytosaveabit

7 hours ago

Hehehe!

$Cellectar BioSciences(CLRB.US)$ Look at that! Good PR price falls! But now its up almost 20% from the low it dropped to

Trytosaveabit

13 hours ago

Just thinking outloud

$Cellectar BioSciences(CLRB.US)$ Hoping that was a great dip for buying? Hehehe. NFA

Trytosaveabit

13 hours ago

Update

$Cellectar BioSciences(CLRB.US)$ Cellectar Biosciences’ Iopofosine I 131 Exceeds Primary Endpoint in Waldenstrom’s Macroglobulinemia Pivotal Study With 78% of Major Response Patients Remaining Progression Free at 18 Months

TrendTrader

Yesterday 00:00

3 🎯 hit!

$Cellectar BioSciences(CLRB.US)$

TrendTrader

Jul 22 10:35

Over 3 looking for 3.4

$Cellectar BioSciences(CLRB.US)$

Jaguar8

May 29 06:19

NEWS

$Cellectar BioSciences(CLRB.US)$
Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides
Cellectar Biosciences (NASDAQ: CLRB) has formed a strategic partnership with City of Hope Cancer Center to evaluate the efficacy of its lead drug, iopofosine I 131, in treating mycosis fungoides (MF), a rare form of non-Hodgkin's lymphoma (NHL). This collaboration aims to initiate trials with around 10 patients by late 2024 or early 202...

Meltyy

May 22 02:52

Biotech Stock Catalyst Watchlist 👀

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics(IOVA.US)$ Phase 2
$Supernus Pharmaceuticals(SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF(BINV.US)$ Phase 2a
$MorphoSys(MOR.US)$ Phase 2
$Nuvation Bio(NUVB.US)$ Phase 2
$ALX Oncology(ALXO.US)$ Phase 2
$BioXcel Therapeutics(BTAI.US)$ Phase 2
$Purple Biotech(PPBT.US)$ Phase 2
$Arcus Biosciences(RCUS.US)$ Phase 2
$Medicenna Therapeutics(MDNAF.US)$ Phase 2b
$Affimed NV(AFMD.US)$ Phase 2
$Barinthus Biotherapeutics(BRNS.US)$ Phase 2b...

Trytosaveabit

Mar 4 05:45

Update

$Cellectar BioSciences(CLRB.US)$ Cellectar Biosciences Reports High Rate of Complete Remission in Investigator Initiated Phase I Study of Iopofosine in Combination with External Beam Radiotherapy in Recurrent Head and Neck Cancer
4 MINUTES AGO, 6:40 AM EST
VIA GLOBENEWSWIRE

JESSE JAMES8832

Jan 30 05:45

Cellectar Biosciences Announces Enrollment of the First Patient in Pediatric High-Grade Gliomas Phase 1b Clinical Study

$Cellectar BioSciences(CLRB.US)$

Trytosaveabit

Jan 25 05:47

Update

$Cellectar BioSciences(CLRB.US)$ Cellectar Biosciences Announces Tranche A Warrants Fully Exercised, Providing Proceeds of $44.1 Million

No comment yet